About Us | Cancer | Chemotherapy Event |Edinburgh

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

A New Era in Oncology: Transforming Cancer Therapy

- Cancer 2025

Welcome Message

The 21^st International Conference on Cancer and Cancer Therapy will be held on February 03-04, 2025, in the historic city of Edinburgh, Scotland. This global event is set to unite leading minds in oncology, research, and healthcare under the theme, "A New Era in Oncology: Transforming Cancer Therapy"

Cancer 2025 offers an exceptional platform for engaging discussions, including keynote sessions, oral presentations, poster displays, and exhibitions that highlight the latest advancements in cancer research and therapeutic strategies.

This conference is an invaluable opportunity for oncologists, researchers, healthcare professionals, and students to explore cutting-edge developments, exchange ideas, and forge meaningful collaborations. Together, we aim to advance the field of cancer care and enhance patient outcomes worldwide.

We warmly welcome you to join us in Edinburgh to contribute to and benefit from this impactful gathering. Let’s work together to shape the future of cancer therapy.

Warm regards,
Larisa John
Program Manager | Cancer 2025
Email: [email protected]

About Conference

The 21st International Conference on Cancer and Cancer Therapy is set to unfold on February 03-04, 2025, amidst the enchanting ambiance of Edinburgh, Scotland. This premier event is dedicated to advancing the understanding, prevention, and treatment of cancer, bringing together a global community of oncologists, researchers, clinicians, and healthcare professionals.

Key Objectives:

Discover Innovations: Learn about ground breaking research, novel therapies, and emerging trends in cancer care.
Share Expertise: Engage in discussions on cutting-edge treatment strategies and clinical practices.
Collaborate Globally: Build connections with peers and experts from around the world.
Explore Technology: Stay informed on the latest advancements in diagnostics, therapeutics, and medical devices.

Why Attend Cancer 2025?

Expert Knowledge
Networking Opportunities
Interactive Learning
Publishing Opportunities
Continuing Education

Conference Highlights:

50+ Global Participants
10+ Inspiring Keynote Speakers
25+ Plenary Sessions
3+ Exhibitors Showcasing Innovations
12 Educational Workshops
B2B Meetings to Foster Collaborations

Hybrid Participation:

Cancer 2025 will be a hybrid event, offering both in-person and virtual attendance options. All sessions will be accessible through the Webex platform, and recordings will be available for six months to ensure participants can revisit or catch up on missed sessions.

We welcome you to participate in this significant conference and play a role in influencing the future of cancer research and therapy. Whether you’re attending in the historic city of Edinburgh or participating virtually, Cancer 2025 promises to be an invaluable experience for advancing your knowledge, networking with experts, and exploring the latest in cancer care.

We look forward to welcoming you to Edinburgh on February 03-04, 2025!

Registration Instructions:

As a Delegate, you'll enjoy keynote speeches from leading experts in cancer research, network with healthcare professionals and researchers, and participate in sessions on the latest therapies. You’ll also explore exhibitions showcasing innovative technologies in cancer care.

As a Speaker, you'll share your research at the conference, advancing knowledge in oncology. You'll present to an international audience, gain recognition as a leader, and enjoy free access to all sessions and events for networking. To apply, submit your abstract or proposal on the conference website, and remember to register to attend.

Students are welcome you to register for this unique opportunity to learn about the latest in cancer research, hear from global experts, and connect with professionals. Benefits include a discounted fee, access to all sessions and workshops, networking with researchers and clinicians, and special Q&A sessions with experts.

Bring your team to the conference with Group Registration and save! Enjoy waived prices for groups of five or more, access to all sessions and workshops, and tailored packages. Groups of five or more receive a 20% discount, applicable to academic institutions, research organizations, and healthcare professionals.

To register, visit our official conference website, select your registration type (Delegate, Speaker, Student, or Group), and complete the online form. After making your payment through secure options, you'll receive a confirmation email with access details.

For any inquiries or assistance, please contact via Email: [email protected]

We look forward to welcoming you to Edinburgh for an inspiring and impactful event!

Market Analysis

The global cancer therapy market is expected to grow significantly from USD 169.39 billion in 2023 to USD 285.96 billion by 2030, at a CAGR of 9.12%. This growth is driven by the rising prevalence of cancer, advancements in treatment options, and the increasing demand for targeted therapies.

Key Market Drivers:

Rising Cancer Incidence: An increase in cancer cases globally is driving demand for effective cancer treatments.
Advancements in Targeted Therapies: Precision medicine, such as targeted therapies, is gaining traction due to its ability to provide more personalized and effective treatment.
Aging Population: As the global population ages, the risk of developing cancer increases, leading to a higher demand for therapies.
Technological Advancements: Innovations like RNA sequencing and next-gen sequencing are helping personalize cancer treatments.

Therapy Type Segmentation:

Chemotherapy: Chemotherapy remains a dominant therapy due to its systemic approach, targeting cancer cells throughout the body.
Radiation Therapy: A common treatment often combined with other therapies like chemotherapy, for localized cancers.
Surgery: Used for tumor removal, often combined with other treatments like chemotherapy and radiation for better outcomes.
Targeted Therapy & Immunotherapy: These therapies are gaining popularity due to their ability to target specific cancer cells, reducing side effects.

Geographic Market Growth:

North America: Dominates the market due to a high cancer incidence, advanced healthcare systems, and extensive insurance coverage.
Europe & Asia-Pacific: Emerging markets in these regions are seeing increasing demand for cancer therapies as awareness grows and healthcare infrastructure improves.

Challenges and Barriers:

Side Effects: Some therapies cause significant side effects, which can limit their widespread use.
High Costs: The cost of cancer therapies is a major barrier, especially in low- and middle-income countries.
COVID-19 Impact: The pandemic affected cancer diagnosis and treatment, leading to delays and reduced patient visits, but recovery is underway.

Recent Developments:

FDA Approvals: Recent FDA approvals for cancer therapies such as atezolizumab (Tecentriq) and Abecma (idecabtagene vicleucel) are expected to expand treatment options and improve patient outcomes.
Innovation in Radiation Therapy: Elekta's new radiation therapy system, Elekta Harmony, is set to enhance cancer treatment precision.

Target Audience:

Cancer Therapy Providers: Pharmaceutical and biotechnology companies offering cancer treatments.
Research Organizations: Institutions studying cancer and treatment innovations.
Healthcare Professionals: Oncologists, surgeons, and other specialists involved in cancer treatment.
Governments and NGOs: Entities focused on healthcare policy, cancer prevention, and treatment access.

The cancer therapy market is evolving rapidly with technological advancements and growing demand for personalized medicine. The market's trajectory is positive, with significant contributions from emerging therapies, regulatory approvals, and an increasing number of cancer cases globally.

Scientific Sessions/Tracks

Cancer encompasses a diverse range of diseases marked by the uncontrolled proliferation and dissemination of abnormal cells. If left unchecked, this uncontrolled growth can lead to fatal outcomes. Cancer has the potential to impact nearly any area of the body and stands as one of the foremost causes of mortality globally.

The development of cancer is influenced by a combination of genetic mutations, environmental factors, and lifestyle choices. Gaining a deeper understanding of cancer and its treatment options is essential for enhancing patient outcomes and improving overall quality of life.

Submit your Abstract on Below Session:

1.Innovations in Cancer Diagnostics

2.Chemotherapy

3.Stem Cells in Cancer Research

4.Plasma Technology in Cancer Treatment

5.Emerging Therapies in Oncology

10.Oral and Oropharyngeal Cancer

11.Dermatologic Oncology

12.Pathology in Cancer Diagnosis and Prognosis

13.Cancer Pathophysiology

14.Cancer Nanotechnology

15.Palliative Care in Cancer

16.Cancer Interventions and Techniques

17.Gynaecologic and Prostate Cancer

18.Cancer Prognosis and Epidemiology

19. Cancer Genomics and Epigenetics

20.Cancer Immunology and Immune Therapies

21.Cancer Pharmacology and Drug Development

22.Types of cancer

23.Case Reports and Case Series

Session 1: Innovations in Cancer Diagnostics

Advancements in cancer diagnostics are revolutionizing early detection, improving accuracy, and enhancing patient outcomes. New technologies, including liquid biopsy and AI-powered imaging, are enabling faster and more precise diagnosis. These innovations are facilitating personalized treatment plans and earlier interventions, significantly impacting the effectiveness of cancer care. This session will focus on the latest diagnostic tools, their clinical applications, and their potential to transform oncology practices.

Tracks:

1.Liquid Biopsy
2.AI in Imaging & Biomarkers in Diagnosis
3.Genomic Profiling
4.Early Detection Techniques
5.Next-Generation Sequencing (NGS)

Related Conferences:

Related Associations:

Related Societies:

Session 2: Chemotherapy

Chemotherapy remains a cornerstone of cancer treatment, targeting rapidly dividing cancer cells to inhibit their growth. Over the years, advances in drug formulations and delivery methods have enhanced its effectiveness while reducing side effects. This session will explore the latest developments in chemotherapy, including combination therapies and novel drug targets, aimed at improving patient outcomes and minimizing toxicities.

Tracks:

1.Advances in Drug Formulations
2.Delivery Methods
3.Combination Therapies
4.Novel Drug Targets
5.Managing Side Effects & Targeted Chemotherapy

Related Societies:

Related Conferences:

Related Associations:

Session 3: Stem Cells in Cancer Research

Stem cells play a critical role in cancer research by offering insights into cancer development, progression, and recurrence. They hold promise in understanding tumor biology and developing more effective treatments. Recent studies have highlighted how cancer stem cells contribute to drug resistance and metastasis, making them a focal point in therapeutic strategies. This session will explore the latest findings in stem cell research and their potential applications in cancer treatment.

Tracks:

1.Cancer Stem Cells
2.Role in Tumor Biology
3.Implications for Treatment
4.Research Advances
5.Challenges in Targeting CSCs

Related Conferences:

Related Associations:

Related Societies:

Session 4: Plasma Technology in Cancer Treatment

Plasma technology is emerging as an innovative approach in cancer treatment, utilizing ionized gases to target and destroy cancer cells. This non-invasive technique offers potential advantages in precision therapy, reducing damage to surrounding healthy tissues. Plasma-based treatments are showing promise in enhancing the effectiveness of traditional therapies and improving patient outcomes. This session will explore the science behind plasma technology and its evolving role in cancer care.

Tracks:

1.Plasma-Based Cancer Therapy
2.Mechanisms of Action
3.Non-Invasive Treatment & Future Perspectives
4.Combination with Traditional Therapies
5.Current Research and Developments

Related Societies:

Related Conferences:

Related Associations:

Session 5: Emerging Therapies in Oncology

Emerging therapies in oncology are transforming the landscape of cancer treatment by focusing on targeted approaches, immunotherapy, and novel drug discoveries. These advancements are offering new hope for patients with previously hard-to-treat cancers. Cutting-edge therapies are not only improving survival rates but also enhancing the quality of life for cancer patients. This session will explore the most promising therapies, including immune checkpoint inhibitors, gene therapy, and other novel treatment strategies.

Tracks:

1.Immunotherapy
2.Targeted Therapy
3.Gene Therapy
4.Combination Treatments
5.Future Directions

Related Conferences:

Related Associations:

Related Societies:

Session 6: Pediatric Oncology

Pediatric oncology focuses on diagnosing and treating cancers in children, a field that requires specialized approaches due to the distinct biology of childhood cancers. Advances in research have led to improved survival rates and the development of less toxic treatments tailored for young patients. This session will delve into the unique challenges of pediatric cancer, current therapies, and emerging treatments aimed at improving outcomes for children battling cancer.

Tracks:

1.Common Childhood Cancers
2.Long-Term Effects and Survivorship
3.Pediatric Chemotherapy
4.Targeted Therapies for Kids
5.Innovative Pediatric Clinical Trials

Related Societies:

Related Conferences:

Related Associations:

Session 7: Radiation Oncology

Radiation oncology plays a pivotal role in the treatment of various cancers by using targeted radiation to shrink tumors or kill cancer cells. Advances in technology, such as precision radiation therapy and proton therapy, have significantly improved treatment accuracy and reduced side effects. This session will explore the latest techniques, applications, and innovations in radiation oncology, focusing on how these treatments are evolving to provide more effective and personalized care for cancer patients.

Tracks:

1.Types of Radiation Therapy
2.Radiation Resistance
3.Stereotactic Radiosurgery
4.Radiation Resistance
5.Future Directions

Related Conferences:

Related Associations:

Related Societies:

Session 8: Breast Cancer

Breast cancer remains one of the most common cancers globally, but advancements in early detection, treatment, and prevention are improving survival rates. Research continues to uncover new insights into the genetic and molecular mechanisms of breast cancer, leading to more targeted therapies. This session will focus on the latest developments in breast cancer diagnosis, treatment options, and strategies for personalized care, offering hope for more effective and less invasive treatments.

Tracks:

1.Genomic Profiling
2.Targeted Therapies
3.Support and Survivorship
4.Immunotherapy in Breast Cancer
5.Chemotherapy and Hormone Therapy

Related Societies:

Related Conferences:

Related Associations:

Session 9: Blood Cancer

Blood cancers, including leukemia, lymphoma, and myeloma, affect the body's blood-forming tissues and immune system. Recent advancements in treatment, such as targeted therapies and immunotherapies, are significantly improving outcomes for patients. This session will explore the latest breakthroughs in blood cancer research, highlighting the progress made in diagnosis, treatment options, and the development of personalized medicine for these complex cancers.

Tracks:

1.Types of Blood Cancer
2.Stem Cell Transplants
3.Targeted Therapies
4.Immunotherapy for Blood Cancer
5.Long-Term Management

Related Conferences:

Related Associations:

Related Societies:

Session 10: Oral and Oropharyngeal Cancer

Oral and oropharyngeal cancers are a diverse group of cancers affecting the mouth, throat, and surrounding structures. With an increasing focus on early detection and prevention, significant strides have been made in understanding the risk factors, such as tobacco use and HPV infection. This session will discuss the latest advances in diagnosing, treating, and preventing oral and oropharyngeal cancers, along with the emerging role of immunotherapy and targeted therapies.

Tracks:

1.Risk Factors
2.Surgical Treatment
3.Radiotherapy and Chemotherapy
4.Immunotherapy and Targeted Therapy
5.Rehabilitation and Quality of Life

Related Societies:

Related Conferences:

Related Associations:

Session 11: Dermatologic Oncology

Dermatologic oncology is dedicated to the diagnosis and management of skin cancers, which encompass melanoma, basal cell carcinoma, and squamous cell carcinoma. With advancements in early detection and targeted therapies, the prognosis for many skin cancer patients has improved. This session will explore the latest research on skin cancer prevention, innovative treatments, and the role of immunotherapy and genetic testing in personalized care. A comprehensive approach to managing skin cancers, including surgery, radiation, and novel therapies, will also be discussed.

Tracks:

1.Types of Skin Cancer
2.Genetic Testing
3.Surgical and Non-Surgical Treatments
4.Immunotherapy in Dermatologic Oncology
5.Prevention and Awareness

Related Conferences:

Related Associations:

Related Societies:

Session 12: Pathology in Cancer Diagnosis and Prognosis

Pathology plays a critical role in cancer diagnosis and prognosis by providing essential insights into the cellular and molecular characteristics of tumors. Through techniques like biopsy, histopathology, and molecular profiling, pathologists help determine the type, stage, and aggressiveness of cancer, guiding treatment decisions. This session will focus on the advancements in diagnostic pathology, the integration of molecular diagnostics, and how these innovations are shaping personalized cancer care and improving patient outcomes.

Tracks:

1.Role of Pathology in Cancer Diagnosis
2.Histopathology Techniques
3.Molecular Profiling in Cancer
4.Cancer Staging and Grading
5.Prognostic Biomarkers & Innovations in Pathology

Related Societies:

Related Conferences:

Related Associations:

Session 13: Cancer Pathophysiology

Cancer pathophysiology explores the complex biological processes that lead to the development and progression of cancer. It involves changes at the molecular, genetic, and cellular levels, including mutations, abnormal cell division, and immune system evasion. This session will delve into the underlying mechanisms driving cancer, examining how tumors form, metastasize, and interact with their environment. Understanding these processes is crucial for developing targeted therapies and improving cancer prevention and treatment strategies.

Tracks:

1.Genetic Mutations
2.Angiogenesis
3.Immune Evasion
4.Metastasis
5.Immune Evasion & Therapeutic Implications

Related Conferences:

Related Associations:

Related Societies:

Session 14: Cancer Nanotechnology

Cancer nanotechnology is an innovative field that applies nanotechnology to detect, diagnose, and treat cancer. By utilizing nanoparticles and nanomaterials, researchers are developing targeted drug delivery systems that can selectively treat cancer cells while minimizing damage to healthy tissue. This session will explore the latest advancements in nanotechnology, including its role in early cancer detection, precision medicine, and the development of novel therapies, offering hope for more effective and less invasive cancer treatments.

Tracks:

1.Nanoparticles for Drug Delivery
2.Nanomaterials in Cancer Therapy
3.Early Detection with Nanotechnology
4.Tumor Imaging Techniques
5.Challenges and Future Directions

Related Societies:

Related Conferences:

Related Associations:

Session 15: Palliative Care in Cancer

Palliative care in cancer focuses on providing relief from the symptoms and suffering associated with cancer, rather than attempting to cure the disease. It is an essential component of cancer care, aimed at improving the quality of life for patients and their families by managing pain, psychological stress, and other symptoms. This session will cover the importance of palliative care in cancer treatment, addressing both physical and emotional needs, and explore the integration of palliative care in all stages of cancer treatment to ensure comprehensive support for patients.

Tracks:

1.Principles of Palliative Care
2.Pain Management
3.Emotional and Psychological Support
4.Integrating Palliative Care
5.Importance of Family Involvement

Related Conferences:

Related Associations:

Related Societies:

Session 16: Cancer Interventions and Techniques

Cancer interventions and techniques encompass a wide range of methods used to diagnose, treat, and manage cancer. These include traditional approaches like surgery, chemotherapy, and radiation, as well as cutting-edge technologies such as targeted therapy and immunotherapy. This session will explore the latest advances in cancer treatment modalities, focusing on how innovative techniques are improving outcomes and offering more personalized treatment options for patients, with an emphasis on minimizing side effects and enhancing recovery.

Tracks:

1.Surgical Interventions
2.Chemotherapy and Radiation
3.Targeted Therapy
4.Immunotherapy
5.Minimally Invasive Techniques

Related Societies:

Related Conferences:

Related Associations:

Session 17: Gynaecologic and Prostate Cancer

Gynecologic and prostate cancers are among the most common types affecting individuals worldwide, with gynecologic cancers including ovarian, uterine, and cervical cancers, and prostate cancer being one of the most prevalent cancers in men. Advances in early detection, treatment, and personalized care have significantly improved patient outcomes. This session will delve into the latest research, treatment options, and preventative strategies for both gynecologic and prostate cancers, emphasizing the importance of early diagnosis and multi-disciplinary care for effective management.

Tracks:

1.Types of Gynecologic Cancers
2.Prostate Cancer Characteristics
3.Symptoms and Diagnosis
4.Treatment Options & Emerging Therapies
5.Patient Support and Care

Related Conferences:

Related Associations:

Related Societies:

Session 18: Cancer Prognosis and Epidemiology

Cancer interventions and techniques involve various methods for diagnosing, treating, and managing cancer. These methods range from conventional approaches such as surgery, chemotherapy, and radiation to advanced technologies like targeted therapy and immunotherapy. This session will examine the most recent developments in cancer treatment options, highlighting how innovative techniques are enhancing patient outcomes and providing more personalized care while aiming to reduce side effects and promote recovery.

Tracks:

1.Cancer Incidence and Prevalence
2.Survival Rates and Prognosis
3.Cancer Epidemiology Methods
4.Early Detection and Screening
5.Global Cancer Burden

Related Societies:

Related Conferences:

Related Associations:

Session 19: Cancer Genomics and Epigenetics

Cancer genomics and epigenetics focus on the genetic and molecular alterations that drive cancer development and progression. Genomic changes, such as mutations and gene amplifications, play a central role in the initiation of cancer, while epigenetic modifications can influence gene expression without altering the DNA sequence. This session will explore the latest discoveries in cancer genomics and epigenetics, highlighting their potential in early detection, targeted therapy, and personalized medicine, which are revolutionizing cancer treatment approaches.

Tracks:

1.Genomic Alterations in Cancer
2.Epigenetic Modifications
3.Next-Generation Sequencing
4.Cancer Biomarkers
5.Therapeutic Implications

Related Conferences:

Related Associations:

Related Societies:

Session 20: Cancer Immunology and Immune Therapies

Cancer immunology focuses on understanding how the immune system interacts with cancer cells, and how tumors evade immune surveillance. Immune therapies, including immunotherapy and checkpoint inhibitors, harness the body’s immune system to target and destroy cancer cells. This session will explore the latest breakthroughs in cancer immunology, highlighting how immune system modulation can enhance cancer treatment, reduce tumor growth, and offer new hope for patients, particularly in cancers resistant to traditional therapies.

Tracks:

1.Immune System and Cancer
2.Immunotherapy Approaches
3.Checkpoint Inhibitors
4.CAR-T Cell Therapy
5.Tumor Microenvironment & Combining Immunotherapies

Related Societies:

Related Conferences:

Related Associations:

Session 21: Cancer Pharmacology and Drug Development

Cancer pharmacology and drug development focus on the creation of new medications aimed at treating cancer more effectively. This includes understanding the mechanisms of drug action, resistance, and the design of targeted therapies. Recent advances in drug development have led to the emergence of more effective and personalized treatments, offering improved survival rates and reduced side effects for patients. This session will explore the latest advancements in cancer drug development, from preclinical research to clinical trials, and the challenges in bringing these therapies to market.

Tracks:

1.Mechanisms of Drug Action
2.Targeted Therapies & Drug Resistance
3.Preclinical Research
4.Clinical Trials
5.Personalized Medicine

Related Conferences:

Related Associations:

Related Societies:

Session 22: Types of cancer

Cancer encompasses a wide range of diseases characterized by uncontrolled cell growth and spread to other parts of the body. Different types of cancer arise in various organs and tissues, with each type having unique characteristics, risk factors, and treatment strategies. Understanding the various cancer types is essential for diagnosing and developing effective treatment plans. This session will explore the most common and rare forms of cancer, highlighting their causes, symptoms, and emerging therapeutic approaches.

Tracks:

1.Carcinoma
2.Sarcomas
3.Leukemias
4.Lymphomas
5.Melanomas & Rare Cancers

Related Societies:

Related Conferences:

Related Associations:

Session 23: Case Reports and Case Series

Case reports and case series are essential tools in understanding the complexities of cancer and its surgical treatment. They offer in-depth insights into individual patient experiences, treatment outcomes, and novel approaches to managing various cancer types. By documenting unique or rare cases, these reports contribute to the body of knowledge, helping healthcare professionals refine diagnostic techniques, treatment protocols, and surgical strategies. This session will highlight significant case studies in cancer surgery, focusing on the lessons learned from specific patient cases and their impact on clinical practice.

Related Conferences:

Related Associations:

Related Societies:

Organizing committee members

Feng Chi Ho, PhD

Professor, WAMS, The World Academy of Medical Sciences, The Netherlands

WAMS, The World Academy of Medical Sciences, The Netherlands, The Netherlands

Mike Robinson, PhD

Director

Founder of the Global Cannabinoid Research, Research Global Cannabinoid Research Center Russia, Russia

Prof. Vladimir N.Anisimov, PhD

Professor

Editor-in-Chief, journal Advances in Gerontology, Carcinogenesis and Oncogerontology N.N. Petrov National Medical Research Center of Oncology, Russia, Russia

Raghavan Rajagopalan, MD

Director

Chief Scientific Officer, Daya Drug Discoveries Inc USA, USA

Inés Llamas Ramos

University of Salamanca, Spain, Spain

Yoshiaki Omura

President of the International College of Acupuncture & Electro-Therapeutics, Cardiology ,Medical Research, Heart Disease Research Foundation USA, USA